Governance of the ICI institute is provided by several complementary bodies that monitor, implement and evaluate the institute’s missions and activities. The institute’s executive office implements and coordinates the initiatives and missions of the ICI.
Meet our executive office
Anthony Gonçalvès
Directeur - Responsable scientifique et technique
Emmanuelle Charafe
Directrice adjointe Formation
Sandrine Roulland
Directrice adjointe Recherche
Cristina Ghirelli
Directrice adjointe MSE&C
Stéphanie Bernard
Attachée de Direction
Our other strategic and operational monitoring bodies
The institute’s aim is to structure excellence in research, training and transfer in oncology and immunology through its steering committees, implement a strategy of training through research and clinical innovation in the following priority areas: fundamental, translational and clinical onco-immunology.
The role of the Institute Council is to administer the institute by managing its broad policies.
Composition:
The Institute Council is made up of members with voting rights in two colleges:
- College 1, comprising the deans (or their representatives) of the science, medicine and pharmacy departments.
- College 2, comprising laboratory directors (or their representatives) CRCM, CIML, TAGC, INP, C2VN, IBDM, LAI.
The following also attend Board meetings in an advisory capacity:
- The Institute's Scientific and Technical Manager, Chairman of the Board
- The Institute's Deputy Training Director
- The Institute's Deputy research director
- The Institute's Project manager
- Institute management attaché
- Directors of the College and Doctoral Schools (ED658) and (ED659)
- IPC General Manager
- AP-HM General Manager
- Clip managers fromIPC andAP-HM
- A representative of AMU-labeled platforms, IBiSA, PIA and biobanks
- A representative of industrial partners within Marseille Immunopole andEurobiomed(AB Sciences, Beckman Coulter, Dynabio, Halio Dx, Imcheck Therapeutics, Innate Pharma)
- A sales representative(SATT-SE, Inserm Transfert, Protisvalor)
- The General Secretary of Cancéropole PACA
- Two representatives of civil society (one patient, one student)
- The heads of programs associated with the Institute.
The Board meets at least twice a year.
To structure excellence in research, training and transfer in the fields of oncology and immunology, the Institute, through its steering committees, implements a strategy combining training through research and clinical innovation.
Composition:
- Emmanuelle Charafe (ICI Deputy training director, PU-PH, IPC/CRCM)
- Sandrine Alibert (Director of the Health Engineering Master's programme, Drugs and Health Products-Drug Design)
- Frédéric André (Director, Master's degree in Integrative Biology and Physiology - BIP)
- Stéphanie Bernard (Executive Assistant, ICI/CRCM/IPC)
- Gabriel Brisou (Clinician, IPC)
- Anne-Sophie Chrétien (Director of Oncology MS Biology-Health, MCU-PH, Pharmacy and CRCM)
- Raynier Devillier (MCU-PH, IPC/CRCM/AMU)
- Christophe Dubois (Co-Director MS Biology-Health, PU, Pharmacy, C2VN)
- Marie-dominique Franco (Project manager, ICI/AMU)
- Franck Galland (Director MS Immunology, PU, Sciences, CIML)
- Florence Gattaceca (Director, Health Engineering Master's programme, Pharmacokinetics)
- Geoffrey Guitard (CRCN/CRCM)
- Aitor Gonzalez (Director, Bio-informatics Master - DLAD)
- Paula Michea (MS Immunology Teaching Team, MCU, CRCM)
- Pierre Morange(Co-Director MS Biology-Health, PU-PH, Faculty of Medical and Paramedical Sciences/C2VN)
- Philippe Naquet (PU MD, CIML)
- Daniel Olive (Director of Oncology MS Biology-Health, PU-PH CE2, APHM/CRCM)
- Julien Royet (Integrative Biology and Physiology Master - BIP)
- Nicolas Terrapon (Co-Director Master Bio-informatics - DLAD)
The Research Steering Committee’s key missions are to promote excellence in fundamental, translational and clinical research, develop cutting-edge technological platforms, and enhance the appeal of the site in order to attract new talent.
- Sandrine roulland (Director DR2, CIML)
- Stéphanie Bernard (Executive Assistant ICI/CRCM/IPC)
- Anne-Sophie Chrétien (MCU-PH, Pharmacy and CRCM)
- Marie-Dominique Franco (Project manager ICI/AMU)
- Sylvain Garciaz (PH, IPC)
- Fanny Mann (DR1, IBDM)
- Pierre Milpied (CRCN/CIML)
- Romain Roncagalli (DR2, CIML)
- Aurélie Tchoghandjian (CRCN/INP)
- Cécile Vicier (PH, IPC)
- Cédric Maurange (DR2, IBDM)
The Socio-economic and Cultural World Steering Committee’s main mission is to design and promote initiatives to encourage the development and integration of socio-economic and cultural issues.
Composition:
- Cristina Ghirelli (Director, Research Operations Director, Imcheck Therapeutics)
- Florence Alesandrini (Health Tech Transfert Manager, Health and Biotherapeutic Fields, sATT South East)
- Stéphanie Bernard (Executive Assistant ICI/CRCM/IPC)
- Marie-Dominique Franco (Project manager ICI/AMU)
- Marie-Anne Hospital (PH, IPC)
- Johanna Kabadanian (Acting Director, Canceropôle PACA)
- Emmanuel Lebouder (Innovation Director, Eurobiomed)
- Marc Lopez (Research Engineer, CRCM)
- Jérémy Magalon (MCU-PH, AMU/AP-HM)
- Vanessa Zepponi (Project Manager, Canceropôle PACA)
The Scientific Training Advisory Board (STAB) is appointed for a three-year term. Its members are appointed by the institute’s Scientific and Technical Manager, on the recommendation or suggestion of in-house teams. STAB also maintains a gender balance and includes members from outside France. Its members are eminent scientists of international renown, specialising in the fields of cancer and immunology.
Composition:
- Christophe Caux (The Cancer Research Center Of Lyon, France)
- Jon Kyte (Oslo University Hospital, Norway)
- Florence Dalenc (Toulouse University Cancer Institute, France)
- Ilaria Malanchi (The Francis Crick Institute, London, United Kingdom)
- Sjaak Neefjes (Leiden University Medical Center, Leiden, Netherlands)
- Fatima Mechta-Grigoriou (Institut curie, Paris, France)
Find out more about the institute
Missions
Aims of the Institute, presentation videos, geographical sites
Ecosystem
Laboratories, faculties, doctoral schools...